Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 3 trial of CRZ capsules versus aripiprazole in adults with acute schizophrenia
CTR20243723Phase 3Completed
- Sponsor
- Zhejiang Huahai Pharmaceutical Co., Ltd.
- Start
- Oct 2024
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of cariprazine, aripiprazole in schizophrenia, sponsored by Zhejiang Huahai Pharmaceutical Co., Ltd.. Started Oct 2024; status: completed.
02
Drugs
cariprazinearipiprazole
03
Conditions
schizophrenia
Beyond the preview
Go deeper on CTR20243723.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20243723.